FG
ABBV icon

Foster Group’s AbbVie ABBV Stock Holding History

Foster Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
9,603
+375
+4% +$80.7K 0.06% 83
2026
Q1 		$2.01M Buy
9,228
+748
+9% +$166K 0.06% 82
2025
Q4 		$1.94M Buy
8,480
+258
+3% +$58.8K 0.06% 81
2025
Q3 		$1.9M Buy
8,222
+101
+1% +$20.6K 0.06% 80
2025
Q2 		$1.51M Buy
8,121
+220
+3% +$40.9K 0.05% 83
2025
Q1 		$1.66M Buy
7,901
+719
+10% +$140K 0.06% 71
2024
Q4 		$1.28M Sell
7,182
-1,162
-14% -$214K 0.05% 73
2024
Q3 		$1.65M Sell
8,344
-2
-0% -$373 0.06% 68
2024
Q2 		$1.43M Buy
8,346
+164
+2% +$27.2K 0.06% 77
2024
Q1 		$1.49M Buy
8,182
+547
+7% +$94.3K 0.07% 71
2023
Q4 		$1.14M Hold
7,635
– – 0.07% 69
2023
Q3 		$1.14M Buy
7,635
+743
+11% +$109K 0.07% 69
2023
Q2 		$929K Sell
6,892
-715
-9% -$105K 0.06% 77
2023
Q1 		$1.21M Buy
7,607
+576
+8% +$88.1K 0.08% 64
2022
Q4 		$1.14M Buy
7,031
+310
+5% +$47.5K 0.08% 60
2022
Q3 		$902K Buy
6,721
+245
+4% +$35.2K 0.07% 60
2022
Q2 		$992K Sell
6,476
-253
-4% -$38.7K 0.07% 63
2022
Q1 		$1.09M Buy
6,729
+406
+6% +$59K 0.09% 58
2021
Q4 		$856K Sell
6,323
-68
-1% -$8.03K 0.07% 65
2021
Q3 		$689K Sell
6,391
-176
-3% -$20.1K 0.07% 70
2021
Q2 		$740K Buy
6,567
+73
+1% +$8.22K 0.09% 69
2021
Q1 		$703K Sell
6,494
-65
-1% -$6.95K 0.11% 57
2020
Q4 		$679K Buy
+6,559
New +$630K 0.13% 47

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Foster Group's ABBV Position: Q2 2026 in Review

Foster Group increased its AbbVie (ABBV) stake by 4.1% in Q2 2026, buying an estimated $80.7K and bringing the position to 9,603 shares worth $2.42M. The position accounts for 0.06% of the portfolio, ranked #83.

Foster Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Foster Group held 9,603 shares of AbbVie worth $2.42M as of Q2 2026.
  • Foster Group bought 375 AbbVie shares in Q2 2026, an estimated $80.7K.
  • AbbVie made up 0.06% of Foster Group's portfolio in Q2 2026, its #83 holding.
  • Foster Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.